Holen Sie sich die Stockscreener-App
20.09
4.15%
0.80
Handel nachbörslich:
20.08
-0.01
-0.05%
Schlusskurs vom Vortag:
$19.29
Offen:
$19.15
24-Stunden-Volumen:
432.45K
Relative Volume:
0.86
Marktkapitalisierung:
$1.12B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.34%
1M Leistung:
+13.70%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$19.00
$20.14
1-Wochen-Bereich:
$18.23
$21.20
52-Wochen-Spanne:
$14.14
$24.99
Omada Health Inc Stock (OMDA) Company Profile
Firmenname
Omada Health Inc
Sektor
Branche
Telefon
888-987-8337
Adresse
500 SANSOME STREET, SAN FRANCISCO
Vergleichen Sie OMDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMDA
Omada Health Inc
|
20.09 | 1.09B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
279.18 | 45.01B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
69.63 | 11.53B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
64.02 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.27 | 8.04B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.35 | 6.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omada Health Inc Stock (OMDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Eingeleitet | Barclays | Overweight |
| 2025-07-01 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-01 | Eingeleitet | Evercore ISI | Outperform |
| 2025-07-01 | Eingeleitet | Goldman | Buy |
| 2025-07-01 | Eingeleitet | JP Morgan | Overweight |
| 2025-07-01 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-07-01 | Eingeleitet | Needham | Buy |
Alle ansehen
Omada Health Inc Aktie (OMDA) Neueste Nachrichten
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
Omada Health, Inc.: Strong Market Position and Growth Potential Justify Buy Rating - TipRanks
Omada grows revenue, membership in public earnings debut - Healthcare Dive
Omada Health 2025 Q2 Earnings Losses Narrow Sharply, 50% Year-Over-Year Reduction in Net Loss - AInvest
Omada Health revenue jumps 49% year-over-year post-IPO - TechTarget
Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 By Investing.com - Investing.com South Africa
Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 - Investing.com Nigeria
Freedom Broker lowers Omada Health stock price target to $20 from $26 - Investing.com India
Freedom Broker lowers Omada Health stock price target to $20 from $26 By Investing.com - Investing.com South Africa
Omada Health price target raised to $28 from $27 at Canaccord - TipRanks
Omada Health price target raised to $24 from $21 at Barclays - TipRanks
Omada Health Reports Strong Q2 2025 Growth - TipRanks
Omada Health reports Q2 EPS (24c), consensus (13c) - TipRanks
Omada Health beats on revenue in first earnings report since IPO - CNBC
Omada Health Reports Second Quarter 2025 Results - The Manila Times
Earnings Flash (OMDA) Omada Health, Inc. Reports Q2 Revenue $61.4M, vs. FactSet Est of $55.3M - MarketScreener
U.S. Digital Therapeutics Market to Witness Remarkable Growth - openPR.com
Omada Health, Inc. (NASDAQ:OMDA) Receives $23.86 Average PT from Analysts - Defense World
Omada Health’s Strategic Partnerships and AI Leverage Drive Growth and Profitability Outlook - TipRanks
Health Coach Market is evolving rapidly Through 2025 To 2032 | Noom, Inc., HealthifyMe, Omada Health - openPR.com
Digital Therapeutics for Diabetes Market is projected to reach - openPR.com
Omada Health: A Buy Rating for a Company with Strong Distribution Partnerships and Clinical Validation - AInvest
Omada Health: Long Growth Runway Ahead - Seeking Alpha
Omada Health Sets Q2 Earnings Date: Virtual Healthcare Leader Reports August 7 - Stock Titan
Interleukin Inhibitors Market Generated Opportunities, Future Scope by 2032 | Noom, Inc., HealthifyMe, Omada Health - openPR.com
Omada Health, Inc.: A Promising Buy Amid Technical Weakness and Growth Potential - TipRanks
IPO market remains 'sluggish' despite recent San Francisco listings - The Business Journals
EQBK issues 1.73M shares, completes NBC merger & adds new director | OMDA SEC FilingForm 4 - Stock Titan
More than $16B in med-tech funding raised through 1H25 - BioWorld MedTech
The Making of Omada Health | Omada Health Co-Founder & CEO Sean Duffy - iHeart
These are the 9 healthcare startups next in line to go public, according to bankers and investors - Business Insider
Omada Health IPO signals healthier market, avoids ‘down-round’ trend - MSN
Health Coach Market Set to Witness Significant Growth by 2025-2032 | Noom, Inc., HealthifyMe, Omada Health - newstrail.com
Omada Health Stock (OMDA): A Growth Story in Digital Health - Value The Markets
Omada Health stock initiated with Buy rating at Freedom Broker - Investing.com
Needham initiates coverage on Omada Health stock with Buy rating By Investing.com - Investing.com India
Omada Health initiated with a Buy at Needham - TipRanks
Omada Health initiated with an Overweight at JPMorgan - TipRanks
Omada Health initiated with an Overweight at Morgan Stanley - TipRanks
Omada Health initiated with an Overweight at Barclays - TipRanks
Don’t expect a wave of digital health IPOs quite yet - Modern Healthcare
Omada Health initiated with a Buy at Goldman Sachs - TipRanks
Omada Health: A Compelling Investment Opportunity in Digital Health with Strong Growth Potential - TipRanks
Omada Health: Strong Growth Prospects and Path to Profitability with Undervalued Potential - TipRanks
The long-awaited digital health IPO is back, but most late-stage healthcare startups aren't ready for it, according to bankers - Business Insider
Here are 12 Bay Area companies to watch for IPOs after Chime - The Business Journals
Omada Health prices IPO at $19 a share, raises $150M - MSN
Caris settles IPO at $21, trading starts at $28 - BioWorld MedTech
Health Coach Market Is Booming So Rapidly 2025-2032 -Noom, Inc., HealthifyMe, Omada Health, Inc., Iora Health - openPR.com
Omada Health releases new data on its GLP-1 companion program - Yahoo Finance
New Data: Omada Health GLP-1 Program Doubles Weight Loss Success vs Standard Care - Stock Titan
Finanzdaten der Omada Health Inc-Aktie (OMDA)
Es liegen keine Finanzdaten für Omada Health Inc (OMDA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
11.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):